Literature DB >> 3925002

Alternative mechanism of protein A-immunoglobulin interaction the VH-associated reactivity of a monoclonal human IgM.

M A Vidal, F P Conde.   

Abstract

The immunoglobulin site(s) that mediates the alternative mechanism of interaction between immunoglobulins and staphylococcal protein A (SpA) was studied by using a monoclonal human IgM. Several IgM fragments were tested for their inhibitory effect in a competitive binding assay of 125I-IgM to SpA. Only those fragments containing Fab mu pieces showed some inhibitory activity. The reactivity of the Fab mu region was retained in some of its subfragments, such as Fv or the VH domain, unlike isolated light chains or VL domains. Furthermore, antibodies specific for the VH domain completely inhibited the SpA-IgM interaction. These results indicate that the alternative SpA-binding site of IgM is located in VH regions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925002

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity.

Authors:  M Graille; E A Stura; A L Corper; B J Sutton; M J Taussig; J B Charbonnier; G J Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Study of binding between protein A and immunoglobulin G using a surface tension probe.

Authors:  L Yang; M E Biswas; P Chen
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

3.  Staphylococcus aureus Cowan I-induced human immunoglobulin responses: preferential IgM rheumatoid factor production and VH3 mRNA expression by protein A-binding B cells.

Authors:  L M Kozlowski; S R Kunning; Y Zheng; L M Wheatley; A I Levinson
Journal:  J Clin Immunol       Date:  1995-05       Impact factor: 8.317

4.  Presentation of antigen in immune complexes is boosted by soluble bacterial immunoglobulin binding proteins.

Authors:  M Léonetti; J Galon; R Thai; C Sautès-Fridman; G Moine; A Ménez
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

5.  In vitro molecular evolution yields an NEIBM with a potential novel IgG binding property.

Authors:  Peipei Qi; Ying-Ying Ding; Ting He; Tong Yang; Qiuli Chen; Jiaojiao Feng; Jinhong Wang; Mingmei Cao; Xiangyu Li; Heng Peng; Huaimin Zhu; Jie Cao; Wei Pan
Journal:  Sci Rep       Date:  2014-11-04       Impact factor: 4.379

6.  Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.

Authors:  Andrew D Tustian; Christine Endicott; Benjamin Adams; John Mattila; Hanne Bak
Journal:  MAbs       Date:  2016-03-10       Impact factor: 5.857

7.  Development of a novel affinity chromatography resin for platform purification of bispecific antibodies with modified protein a binding avidity.

Authors:  Andrew D Tustian; Linus Laurin; Henrik Ihre; Travis Tran; Robert Stairs; Hanne Bak
Journal:  Biotechnol Prog       Date:  2018-03-08

8.  The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A.

Authors:  J L Hillson; N S Karr; I R Oppliger; M Mannik; E H Sasso
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.